- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 27.01. | Bluejay Diagnostics announces 1-for-4 reverse stock split | 3 | Seeking Alpha | ||
| 27.01. | Bluejay Diagnostics, Inc.: Bluejay Diagnostics Announces 1-for-4 Reverse Stock Split | 50 | GlobeNewswire (Europe) | ACTON, Mass., Jan. 27, 2026 (GLOBE NEWSWIRE) -- Bluejay Diagnostics, Inc. (NASDAQ: BJDX) ("Bluejay" or the "Company"), a medical technology company developing rapid diagnostics on its Symphony platform... ► Artikel lesen | |
| 30.12.25 | Bluejay Diagnostics, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 29.12.25 | Bluejay Diagnostics schließt Antikörper-Produktion für IL-6-Testsystem ab | 1 | Investing.com Deutsch | ||
| 29.12.25 | Bluejay Diagnostics completes antibody production for IL-6 test system | 5 | Investing.com | ||
| 29.12.25 | Bluejay Diagnostics, Inc.: Bluejay Diagnostics Announces Completion of Commercial-Scale IL-6 Antibody Production | 235 | GlobeNewswire (Europe) | ACTON, Mass., Dec. 29, 2025 (GLOBE NEWSWIRE) -- Bluejay Diagnostics, Inc. (NASDAQ: BJDX) ("Bluejay" or the "Company") announced that it has completed commercial-scale production of both polyclonal... ► Artikel lesen | |
| 10.11.25 | Bluejay Diagnostics, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 10.11.25 | Bluejay Diagnostics reports progress on sepsis test clinical trial | 4 | Investing.com | ||
| BLUEJAY DIAGNOSTICS Aktie jetzt für 0€ handeln | |||||
| 10.11.25 | Bluejay Diagnostics, Inc.: Bluejay Diagnostics Corporate Update: Advancing Clinical Milestones and Strategic Partnerships | 131 | GlobeNewswire (Europe) | Company focused on advancing clinical milestones and strategic partnerships, with goal of positioning itself for future FDA clearance and product commercialization.Patient enrollment in SYMON-II clinical... ► Artikel lesen | |
| 07.11.25 | Bluejay Diagnostics, Inc. - 10-Q, Quarterly Report | - | SEC Filings | ||
| 23.10.25 | Bluejay Diagnostics files to sell 6.93M shares of common stock for holders | 2 | Seeking Alpha | ||
| 10.10.25 | Bluejay Diagnostics closes $4.5 million private placement | 1 | Investing.com | ||
| 10.10.25 | Bluejay Diagnostics, Inc.: Bluejay Diagnostics Announces Closing of $4.5 Million Private Placement Priced At-The-Market Under Nasdaq Rules | 2 | GlobeNewswire (USA) | ||
| 09.10.25 | Bluejay Diagnostics raises $4.5 million in private placement | 3 | Investing.com | ||
| 09.10.25 | Bluejay Diagnostics sichert sich 4,5 Millionen US-Dollar durch Privatplatzierung | 2 | Investing.com Deutsch | ||
| 09.10.25 | Bluejay Diagnostics, Inc.: Bluejay Diagnostics Announces $4.5 Million Private Placement Priced At-the-Market Under Nasdaq Rules | 1 | GlobeNewswire (USA) | ||
| 09.10.25 | Bluejay Diagnostics stock soars after expanding manufacturing partnership | 2 | Investing.com | ||
| 09.10.25 | Bluejay Diagnostics expands partnership with SanyoSeiko for Symphony platform | 4 | Investing.com | ||
| 09.10.25 | Bluejay Diagnostics, Inc.: Bluejay Diagnostics and SanyoSeiko Expand Strategic Partnership to Advance Commercialization of Symphony Platform | 238 | GlobeNewswire (Europe) | ACTON, Mass. and YAMANASHI, Japan, Oct. 09, 2025 (GLOBE NEWSWIRE) -- Bluejay Diagnostics, Inc. (NASDAQ: BJDX) ("Bluejay"), a medical diagnostics company focused on developing rapid near-patient testing... ► Artikel lesen | |
| 09.10.25 | Bluejay Diagnostics, Inc. - 8-K, Current Report | 1 | SEC Filings |
1 2 Weiter >>
23 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| CARL ZEISS MEDITEC | 27,520 | +0,66 % | BARCLAYS stuft CARL ZEISS MEDITEC AG auf 'Equal Weight' | LONDON (dpa-AFX Analyser) - Die britische Investmentbank Barclays hat das Kursziel für Carl Zeiss Meditec von 49 auf 32 Euro gesenkt und die Aktien von "Overweight" auf "Equal Weight" abgestuft. Nur... ► Artikel lesen | |
| GE HEALTHCARE TECHNOLOGIES | 68,54 | +0,53 % | GE HealthCare Technologies Inc. Reveals Retreat In Q4 Profit | WASHINGTON (dpa-AFX) - GE HealthCare Technologies Inc. (GEHC) reported earnings for fourth quarter that Drops, from the same period last yearThe company's earnings totaled $589 million, or $1.29... ► Artikel lesen | |
| CLOVER HEALTH INVESTMENTS | 1,781 | -1,38 % | Clover Health Investments, Corp.: Clover Health Announces Chelsea Clinton to Step Down from Board Following Eight Years of Service | WILMINGTON, Del., Oct. 31, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) ("Clover," "Clover Health" or the "Company") today announced that Chelsea Clinton, the longest-serving... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 41,400 | -2,82 % | HV-Termine: Hauptversammlungen bei Adv. Blockchain, Aurubis, Fortec, Schott, Siemens, Healthineers, Stabilus, TUI | Einmal jährlich müssen sich Aufsichtsrat und Vorstand einer Gesellschaft den Aktionären stellen: Die Hauptversammlung ist das höchste Organ einer Aktiengesellschaft und vergleichbarer Unternehmens-Formen.... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 40,640 | +0,40 % | Fresenius Medical Care: Ein Neuanfang nach turbulenten Zeiten? | ||
| FRESENIUS | 49,760 | +1,06 % | JEFFERIES stuft Fresenius SE auf 'Buy' | NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat die Einstufung für Fresenius mit einem Kursziel von 55 Euro auf "Buy" belassen. Die Bad Homburger seien in Verjüngungskur, und der Markt preise... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 28,740 | +4,89 % | PROCEPT BioRobotics Reports Third Quarter 2025 Financial Results and Issues 2026 Revenue Guidance | SAN JOSE, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 39,680 | +3,44 % | BrightSpring Health Services, Inc. to Announce Fourth Quarter and Full Year 2025 Financial Results on February 27, 2026 | ||
| HEARTFLOW | 27,690 | +6,54 % | Heartflow, Inc.: Heartflow FFRCT Analysis Delivers Prognostic Power and Significant Cost Savings in New Analyses of Over 90,000 Patients with Coronary Artery Disease | Lesion-specific FFRCT predicts individual cardiovascular outcomes and delivers greater-than-modeled cost savings for real-world population in FISH&CHIPS analyses from England's National Health ServiceMOUNTAIN... ► Artikel lesen | |
| GENEDX | 84,35 | +0,32 % | GeneDx to Participate in Upcoming Investor Conferences | GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced that company management will participate in upcoming investor conferences:
Stifel... ► Artikel lesen | |
| PRIVIA HEALTH GROUP | 21,990 | +2,23 % | Privia Health Group, Inc.: Privia Health Reports Third Quarter 2025 Financial Results | Very Strong Third Quarter and Year-to-Date Performance Across the BusinessNet Income +94.1% and Adjusted EBITDA +61.6% compared to 3Q'24Implemented Providers +13.1% and Practice Collections +27.1%... ► Artikel lesen | |
| GERRESHEIMER | 25,660 | +1,99 % | JEFFERIES stuft GERRESHEIMER AG auf 'Buy' | NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat die Einstufung für Gerresheimer mit einem Kursziel von 34,10 Euro auf "Buy" belassen. Analyst James Vane-Tempest zählt den Spezialverpackungshersteller... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 21,750 | +2,84 % | 6 Analysts Have This To Say About Alignment Healthcare | ||
| PROGYNY | 21,960 | +0,18 % | Progyny, Inc. Announces Third Quarter 2025 Results | Reports Revenue of $313.3 Million, Reflecting 9.3% GrowthRaises Full Year Guidance to Reflect Continued Strength in Member EngagementSelling Season Yields Over 80 New Clients, 900,000 New Lives, and... ► Artikel lesen | |
| HIMS & HERS HEALTH | 19,500 | +0,15 % | Hims & Hers-Aktie -10%: Warum profitiert sie nicht? | Die Hims & Hers-Aktie schoss am gestrigen Donnerstag kurzfristig um über +10% in die Höhe, beendete den Handelstag dann aber doch mit einem Minus von fast -4%. Am Freitagmorgen bricht der Kurs der Gesundheitsplattform... ► Artikel lesen |
Das Unternehmen BLUEJAY DIAGNOSTICS INC kann der Branche Gesundheitswesen zugeordnet werden. Die relative Kursveränderung beträgt aktuell +15,63 % bei einem Aktienkurs von 3,440 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu BLUEJAY DIAGNOSTICS INC finden Sie auf Wallstreet Online.